| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* INSERM U.466, Biochemistry Department, University Paul Sabatier, Toulouse, France;
Laboratorio de Bioquimica, Faculdade de Farmacia and Centro de Neurociências, Universidade de Coimbra, 3000 Coimbra, Portugal;
Institute of Medical Biochemistry, Karl-Franzen Universität Graz, Austria; and
§ Institute of Biochemistry, University of Fribourg, Switzerland
1Correspondence: INSERM U-466 and Biochimie, CHU Rangueil, 1 Avenue Jean Poulhès, 31403 Toulouse Cedex 04, France. E-mail: anesalv{at}rangueil.inserm.fr or salvayre{at}rangueil.inserm.fr
Oxidized low-density lipoproteins (oxLDL) play a role in the genesis of atherosclerosis. OxLDL are able to induce apoptosis of vascular cells, which is potentially involved in the formation of the necrotic center of atherosclerotic lesions, plaque rupture, and subsequent thrombotic events. Because oxLDL may induce structural modifications of cell protein and altered proteins may impair cell viability, the present work aimed to evaluate the extent of protein alterations, the degradation of modified proteins through the ubiquitin-proteasome system (a major degradative pathway for altered and oxidatively modified proteins) and their role during apoptosis induced by oxLDL. This paper reports the following: 1) oxLDL induce derivatization of cell proteins by 4-hydroxynonenal (4-HNE) and ubiquitination. 2) Toxic concentrations of oxLDL elicit a biphasic effect on proteasome activity. An early and transient activation of endogenous proteolysis is followed rapidly by a subsequent decay (resulting probably from the 26S proteasome inhibition) and followed later by the inhibition of the 20S proteasome (as assessed by inhibition of sLLVY-MCA hydrolysis). 3) Specific inhibitors of proteasome (lactacystin and proteasome inhibitor I) potentiated considerably the toxicity of oxLDL (nontoxic doses of oxLDL became severely toxic). The defect of the ubiquitination pathway (in temperature-sensitive mutants) also potentiated the toxicity of oxLDL. This suggests that the ubiquitin-proteasome pathway plays a role in the cellular defenses against oxLDL-induced toxicity. 4) Dinitrophenylhydrazine (DNPH), an aldehyde reagent, prevented both the oxLDL-induced derivatization of cell proteins and subsequent cytotoxicity. Altogether, the reported data suggest that both derivatization of cell proteins (by 4-HNE and other oxidized lipids) and inhibition of the proteasome pathway are involved in the mechanism of oxLDL-induced apoptosis.—Vieira, O., Escargueil-Blanc, I., Jürgens, G., Borner, C., Almeida, L., Salvayre, R., Nègre-Salvayre, A. Oxidized LDL alter the activity of the ubiquitin-proteasome pathway: potential role in oxidized LDL-induced apoptosis.
Key Words: oxidized LDL • 4-hydroxynonenal • proteasome • ubiquitin • apoptosis
This article has been cited by other articles:
|
|
 |
|
  T. Fukai Targeting Proteasome Worsens Atherosclerosis Circ. Res., October 26, 2007; 101(9): 859 - 861. [Full Text] [PDF]
|
|
|
|
|
|
J. Herrmann, A. M. Saguner, D. Versari, T. E. Peterson, A. Chade, M. Olson, L. O. Lerman, and A. Lerman Chronic Proteasome Inhibition Contributes to Coronary Atherosclerosis Circ. Res., October 26, 2007; 101(9): 865 - 874. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kovacs, P. Tornvall, R. Nilsson, J. Tegner, A. Hamsten, and J. Bjorkegren Human C-reactive protein slows atherosclerosis development in a mouse model with human-like hypercholesterolemia PNAS, August 21, 2007; 104(34): 13768 - 13773. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Vindis, I. Escargueil-Blanc, M. Elbaz, B. Marcheix, M.-H. Grazide, K. Uchida, R. Salvayre, and A. Negre-Salvayre Desensitization of Platelet-Derived Growth Factor Receptor-{beta} by Oxidized Lipids in Vascular Cells and Atherosclerotic Lesions: Prevention by Aldehyde Scavengers Circ. Res., March 31, 2006; 98(6): 785 - 792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. R. Chade, J. Herrmann, X. Zhu, J. D. Krier, A. Lerman, and L. O. Lerman Effects of Proteasome Inhibition on the Kidney in Experimental Hypercholesterolemia J. Am. Soc. Nephrol., April 1, 2005; 16(4): 1005 - 1012. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vindis, M. Elbaz, I. Escargueil-Blanc, N. Auge, A. Heniquez, J.-C. Thiers, A. Negre-Salvayre, and R. Salvayre Two Distinct Calcium-Dependent Mitochondrial Pathways Are Involved in Oxidized LDL-Induced Apoptosis Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 639 - 645. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Martinet, M. De Bie, D. M. Schrijvers, G. R.Y. De Meyer, A. G. Herman, and M. M. Kockx 7-Ketocholesterol Induces Protein Ubiquitination, Myelin Figure Formation, and Light Chain 3 Processing in Vascular Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2296 - 2301. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Chade, M. Rodriguez-Porcel, J. Herrmann, X. Zhu, J. P. Grande, C. Napoli, A. Lerman, and L. O. Lerman Antioxidant Intervention Blunts Renal Injury in Experimental Renovascular Disease J. Am. Soc. Nephrol., April 1, 2004; 15(4): 958 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Herrmann, A. Ciechanover, L. O Lerman, and A. Lerman The ubiquitin-proteasome system in cardiovascular diseases--a hypothesis extended Cardiovasc Res, January 1, 2004; 61(1): 11 - 21. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Chade, M. Rodriguez-Porcel, J. P. Grande, X. Zhu, V. Sica, C. Napoli, T. Sawamura, S. C. Textor, A. Lerman, and L. O. Lerman Mechanisms of Renal Structural Alterations in Combined Hypercholesterolemia and Renal Artery Stenosis Arterioscler. Thromb. Vasc. Biol., July 1, 2003; 23(7): 1295 - 1301. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bacot, N. Bernoud-Hubac, N. Baddas, B. Chantegrel, C. Deshayes, A. Doutheau, M. Lagarde, and M. Guichardant Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses J. Lipid Res., May 1, 2003; 44(5): 917 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Shah Mechanisms of plaque vulnerability and rupture J. Am. Coll. Cardiol., February 19, 2003; 41(4_Suppl_S): 15S - 22S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Herrmann, W. D. Edwards, D. R. Holmes Jr, K. L. Shogren, L. O. Lerman, A. Ciechanover, and A. Lerman Increased ubiquitin immunoreactivity in unstable atherosclerotic plaques associated with acute coronary syndromes J. Am. Coll. Cardiol., December 4, 2002; 40(11): 1919 - 1927. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-J. Geng and P. Libby Progression of Atheroma: A Struggle Between Death and Procreation Arterioscler. Thromb. Vasc. Biol., September 1, 2002; 22(9): 1370 - 1380. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Ardans, A. P. Economou, J. M. Martinson Jr., M. Zhou, and L. M. Wahl Oxidized low-density and high-density lipoproteins regulate the production of matrix metalloproteinase-1 and -9 by activated monocytes J. Leukoc. Biol., June 1, 2002; 71(6): 1012 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Escargueil-Blanc, R. Salvayre, N. Vacaresse, G. Jurgens, B. Darblade, J.-F. Arnal, S. Parthasarathy, and A. Negre-Salvayre Mildly Oxidized LDL Induces Activation of Platelet-Derived Growth Factor {beta}-Receptor Pathway Circulation, October 9, 2001; 104(15): 1814 - 1821. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D.Y Li, H.J Chen, and J.L Mehta Statins inhibit oxidized-LDL-mediated LOX-1 expression, uptake of oxidized-LDL and reduction in PKB phosphorylation Cardiovasc Res, October 1, 2001; 52(1): 130 - 135. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Cao, W. Pei, J. Lan, R. A. Stetler, Y. Luo, T. Nagayama, S. H. Graham, X.-M. Yin, R. P. Simon, and J. Chen Caspase-Activated DNase/DNA Fragmentation Factor 40 Mediates Apoptotic DNA Fragmentation in Transient Cerebral Ischemia and in Neuronal Cultures J. Neurosci., July 1, 2001; 21(13): 4678 - 4690. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. NAPOLI, O. QUEHENBERGER, F. DE NIGRIS, P. ABETE, C. K. GLASS, and W. PALINSKI Mildly oxidized low density lipoprotein activates multiple apoptotic signaling pathways in human coronary cells FASEB J, October 1, 2000; 14(13): 1996 - 2007. [Abstract] [Full Text]
|
|
|
|
 |
|
 Y. Yang, J.-Z. Cheng, S. S. Singhal, M. Saini, U. Pandya, S. Awasthi, and Y. C. Awasthi Role of Glutathione S-Transferases in Protection against Lipid Peroxidation. OVEREXPRESSION OF hGSTA2-2 IN K562 CELLS PROTECTS AGAINST HYDROGEN PEROXIDE-INDUCED APOPTOSIS AND INHIBITS JNK AND CASPASE 3 ACTIVATION J. Biol. Chem., May 25, 2001; 276(22): 19220 - 19230. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
